COVID-19 vaccine that has been submitted for regulatory approval.Maryland-based Novavax quietly applied on Friday for Health Canada to approve its vaccine, which studies have suggested is effective against the British and South African variants of the virus.
Canada finalizes Novavax deal to buy up to 72 million more COVID-19 vaccine doses The application comes less than two weeks after Ottawa finalized an agreement with the company for 52 million doses of the vaccine, with an option to purchase another 24 million.[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]The regulatory review also comes as Ottawa continues pressing the European Union on new controls on the export of vaccines from the.